Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grüner

Showing results (601-610 of 673) with videos related to

Pageof 68
Sort By:
Chemmedchem|August 1, 2015
Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney DiseasesMatthias Nettekoven, Jean-Michel Adam, Stefanie Bendels, et al.
Cell Reports|April 6, 2025
PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinomaBen Zhao, Rui Fang, Hendrik Schürmann, et al.
European Journal of Medicinal Chemistry|June 8, 2020
Sulfonamido carboranes as highly selective inhibitors of cancer-specific carbonic anhydrase IXJana Dvořanová, Michael Kugler, Josef Holub, et al.
Journal of Medicinal Chemistry|October 31, 2009
Design of HIV protease inhibitors based on inorganic polyhedral metallacarboranesPavlína Rezácová, Jana Pokorná, Jirí Brynda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2015
CD4+ T cell-derived IL-21 and deprivation of CD40 signaling favor the in vivo development of granzyme B-expressing regulatory B cells in HIV patientsChristof Kaltenmeier, Ali Gawanbacht, Thamara Beyer, et al.
Cellular Microbiology|May 1, 2016
Breadth of humoral response and antigenic targets of sporozoite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infectionKaitian Peng, Yun Shan Goh, Anthony Siau, et al.
Journal of Medicinal Chemistry|October 1, 2019
Metallacarborane Sulfamides: Unconventional, Specific, and Highly Selective Inhibitors of Carbonic Anhydrase IXBohumír Grüner, Jiří Brynda, Viswanath Das, et al.
Iscience|January 4, 2024
KDM5B predicts temozolomide-resistant subclones in glioblastomaVivien Ullrich, Sarah Ertmer, Anna Baginska, et al.
Oncology|October 25, 2014
Palliative treatment of colorectal cancer with secondary metastasis resection in Germany - impact of the multidisciplinary treatment approach on prognosis and cost: the Northern Bavaria IVOPAK I ProjectAxel Wein, Martin Emmert, Susanne Merkel, et al.
Nature Communications|May 13, 2026
Targeted degradation of USP7 in solid cancer cells reveals distinct effects of deubiquitinase degraders and inhibitorsNikolas Klink, Sebastian Urban, Johanna A Seier, et al.
Pageof 68

Showing results (601-610 of 673) with videos related to

Sort By:
Pageof 68
Chemmedchem|August 1, 2015
Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney DiseasesMatthias Nettekoven, Jean-Michel Adam, Stefanie Bendels, et al.
Cell Reports|April 6, 2025
PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinomaBen Zhao, Rui Fang, Hendrik Schürmann, et al.
European Journal of Medicinal Chemistry|June 8, 2020
Sulfonamido carboranes as highly selective inhibitors of cancer-specific carbonic anhydrase IXJana Dvořanová, Michael Kugler, Josef Holub, et al.
Journal of Medicinal Chemistry|October 31, 2009
Design of HIV protease inhibitors based on inorganic polyhedral metallacarboranesPavlína Rezácová, Jana Pokorná, Jirí Brynda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2015
CD4+ T cell-derived IL-21 and deprivation of CD40 signaling favor the in vivo development of granzyme B-expressing regulatory B cells in HIV patientsChristof Kaltenmeier, Ali Gawanbacht, Thamara Beyer, et al.
Cellular Microbiology|May 1, 2016
Breadth of humoral response and antigenic targets of sporozoite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infectionKaitian Peng, Yun Shan Goh, Anthony Siau, et al.
Journal of Medicinal Chemistry|October 1, 2019
Metallacarborane Sulfamides: Unconventional, Specific, and Highly Selective Inhibitors of Carbonic Anhydrase IXBohumír Grüner, Jiří Brynda, Viswanath Das, et al.
Iscience|January 4, 2024
KDM5B predicts temozolomide-resistant subclones in glioblastomaVivien Ullrich, Sarah Ertmer, Anna Baginska, et al.
Oncology|October 25, 2014
Palliative treatment of colorectal cancer with secondary metastasis resection in Germany - impact of the multidisciplinary treatment approach on prognosis and cost: the Northern Bavaria IVOPAK I ProjectAxel Wein, Martin Emmert, Susanne Merkel, et al.
Nature Communications|May 13, 2026
Targeted degradation of USP7 in solid cancer cells reveals distinct effects of deubiquitinase degraders and inhibitorsNikolas Klink, Sebastian Urban, Johanna A Seier, et al.
Pageof 68